Search results
... Boosting Combination Therapy for Myelodysplastic Syndrome (pre-Leukemia) Treatment: A Milestone...
Digital Journal· 8 hours agoThe Company and its subsidiary BioLite, Inc. had entered into a definitive agreement with OncoX BioPharma, Inc., a private company registered in the British Virgin Islands, to collaborate...
Support floods in for 5-year-old Northfield girl battling leukemia
WJW via Yahoo News· 19 hours ago“By Monday, she still had the same symptoms but did not even want to get up out of bed, so I was...
Syrian first lady Asma Assad diagnosed with leukemia, president’s office says
The Washington Times· 4 days agoSyrian first lady Asma Assad has been diagnosed with leukemia, the office of President Bashar Assad...
Chicago Med Season 9 Episode 13 Review: I Think I Know You But Do I Really?
TV Fanatic· 2 days agoBetween tearjerkers, it managed to set up some cliffhangers for season 10 that'll keep viewers...
Syria's first lady diagnosed with leukemia
Investing.com· 4 days agoSyria's first lady diagnosed with leukemia
Many Are Convinced That Gypsy Rose Blanchard Was Never Actually Abused
TheBlast via Yahoo News· 3 days agoThe Blast can confirm that weak muscle tone, or hypotonia, is a common symptom of microdeletions....
Choanephora infundibulifera Rhinosinusitis in Man with Acute Lymphoblastic Leukemia, Tennessee, USA
Centers for Disease Control and Prevention· 22 hours agoChoanephora infundibulifera Rhinosinusitis
St. Jude patient's lifesaving story: 'I was losing my ability to function at that point'
ABC 13 Lynchburg· 2 days agoDoctors diagnosed Anna with acute myeloid leukemia, an aggressive form of the disease, when she was...
In the news | Arkansas Democrat Gazette
Arkansas Democrat-Gazette· 3 days agoAsma Assad, wife of Syrian President Bashar Assad, was diagnosed with acute myeloid leukemia -- an aggressive cancer of the bone marrow and blood --...
Rigel Announces Presentations at the Upcoming 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress
FOX21 Colorado Springs· 1 day agoOral presentation of final five-year results from the registrational Phase 2 trial in R/R mIDH1 AML patients reinforces REZLIDHIA® (olutasidenib) efficacy in heavily pretreated patients, including ...